Core Viewpoint - Yongtai Bio-B (06978.HK) has announced a conditional agreement to issue new convertible bonds and notes, aimed at repaying existing convertible bonds due in February 2026 [1] Group 1: Financial Details - The company will issue new convertible bonds amounting to RMB 270 million, with an initial conversion price of HKD 2.92 per share [1] - Additionally, the company will issue notes amounting to RMB 30 million [1] - The proceeds from the issuance will be used exclusively for the full repayment of the 2023 convertible bonds maturing on February 20, 2026 [1] Group 2: Share Issuance Impact - Upon full exercise of the conversion rights attached to the new convertible bonds, a maximum of 102,880,787 shares will be issued, representing approximately 16.66% of the existing issued shares and about 14.28% of the enlarged issued shares post-issuance [1] Group 3: Conditions and Agreements - The issuance of the new convertible bonds and notes is contingent upon the company paying the accrued unpaid interest on the 2023 convertible bonds and fulfilling other specified conditions [1] - Investors are required to sign a repayment deed benefiting the company, confirming the full and final repayment of the 2023 convertible bonds upon receipt of the new bonds and notes [1]
永泰生物-B(06978.HK)拟发行3亿元新可换股债券及票据 置换到期旧债